Suzuken Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Full Year Ending March 31, 2018
February 04, 2018
Share
Suzuken Co., Ltd. announced consolidated earnings results for the nine months ended December 31, 2017. For the period, the company reported net sales of ¥1,617,280 million, operating income of ¥13,970 million, ordinary income of ¥21,168 million, income before income taxes and non-controlling interests of ¥22,461 million, net income attributable to owners of the parent of ¥14,942 million or ¥157.24 basic income per share, compared to the net sales of ¥1,613,820 million, operating income of ¥13,672 million, ordinary income of ¥20,692 million, income before income taxes and non-controlling interests of ¥26,417 million, net income attributable to owners of the parent of ¥17,443 million or ¥176.63 basic income per share, for the same period a year ago.
The company provided earnings guidance for the full year ending March 31, 2018. For the year, the company expects net sales of ¥2,111,500 million, operating income of ¥13,600 million, ordinary income of ¥22,950 million, net income attributable to owners of the parent of ¥15,850 million or ¥166.93 income per share.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Suzuken Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Full Year Ending March 31, 2018